Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-NAME and Midodrine for Orthostatic Hypotension in Tetraplegia
NCT00835224Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- May 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ng-nitro-l-arginine methyl ester, midodrine in orthostatic hypotension (OH), sponsored by United States Department of Veterans Affairs. Started May 2010; status: completed.
02
Drugs
ng-nitro-l-arginine methyl estermidodrine
03
Conditions
orthostatic hypotension (OH)
Beyond the preview
Go deeper on NCT00835224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835224.